(Q40181966)

18 September 2017

title

The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth (English)

1 reference

18 September 2017

Chung Kwon Kim

1

1 reference

18 September 2017

Sung Hee Hong

2

1 reference

18 September 2017

Young Ae Joe

3

1 reference

18 September 2017

Byoung-Shik Shim

4

1 reference

18 September 2017

Suk-Keun Lee

5

1 reference

18 September 2017

Yong-Kil Hong

6

1 reference

18 September 2017

publication date

1 February 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

98

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

253-258

1 reference

The future of therapy for glioblastoma

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Angiogenic inhibitors: a new therapeutic strategy in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Molecular mechanisms of glioma invasiveness: the role of proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

Pathophysiological consequences of VEGF-induced vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00378.X

10.1111/J.1349-7006.2006.00378.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference